FDA Approves Unknown Drug — BARR

# FDA Approves Generic Drug Application for Barr Pharmaceuticals Barr Pharmaceuticals received FDA approval for ANDA077083 on September 13, 2005, expanding its generic drug portfolio and positioning the company to capture market share in an additional therapeutic category. The approval strengthens Barr's competitive position in the growing generic pharmaceuticals market, potentially offering cost-effective treatment alternatives to healthcare providers and patients.